Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study

@inproceedings{Talmage2017NatalizumabSP,
  title={Natalizumab stabilizes physical, cognitive, MRI, and OCT markers of disease activity: A prospective, non-randomized pilot study},
  author={Garrick D. Talmage and Oscar J. M. Coppes and Adil Javed and Jacqueline Bernard},
  booktitle={PloS one},
  year={2017}
}
Natalizumab is an effective therapy for multiple sclerosis (MS). Its effectiveness has been demonstrated in several clinical and imaging studies. The objective of this study was to further demonstrate the efficacy of natalizumab using a comprehensive battery of clinical and imaging markers in the same cohort of patients followed longitudinally, hence… CONTINUE READING